Compositions and methods to regulate Renalase in the treatment of cancer
US12152085B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2022 |
| Grant date | Nov 26, 2024 |
| Priority date | — |
| Expiry date | May 20, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/90209
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.